The use of calsurf in infants with acute respiratory distress syndrome

The use of surfactant in infants with acute respiratory distress syndrome due to pneumonia

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-17011351

Enrollment

Unknown

Registered

2017-05-11

Start date

2017-05-22

Completion date

Unknown

Last updated

2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infants pneumonia

Interventions

surfactant group and control group:surfactant therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The diagnose of ARDS is confirmed; 2. aged less than 28 days (include 28 days); 3. written informed consent by a parent or guardian.

Exclusion criteria

Exclusion criteria: Exclusion criteria are respiratory failure caused by non-respiratory diseases,or combined with congenital diseases

Design outcomes

Primary

Measure	Time frame
blood gas analysis;complication;ventilation parameter;	—

Countries

China

Contacts

Public ContactChang Liwen

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

lwchang@tjh.tjmu.edu.cn+86 13971619293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026